V
Power Law company profile
Viela Bio
Biotech & Life Sciences · Gaithersburg, United States · Founded 2018 · IPO 2019 Unicorn
Valuation
$3.05B
Market cap · 2026
Revenue
$12M
Latest reported FY
Patent intelligence
$43M patent portfolio · 34 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$43M
1.4% of market cap · 47.5× smaller than top peer Ablynx ($2B)
34 active patent families
Where Viela Bio innovates
Molecular biologyAutoimmune diseaseAutoimmune conditionBiochemistryPharmacology
Above peer median on Strategic · Below peer median on Market
Quality vs same-sector peers
Viela Bio on the five Patsnap quality dimensions
Viela Bio in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Viela Bio concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Viela Bio and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Viela Bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.